**10. References**


Probiotics and Atopic Dermatitis 343

Dani,C., Biadaioli,R., Bertini,G., Martelli,E., and Rubaltelli,F.F. (2002). Probiotics feeding in

Demehri,S., Morimoto,M., Holtzman,M.J., and Kopan,R. (2009). Skin-derived TSLP triggers progression from epidermal-barrier defects to asthma. PLoS. Biol. *7*, e1000067. Dillon,S.R., Sprecher,C., Hammond,A., Bilsborough,J., Rosenfeld-Franklin,M., Presnell,S.R.,

Doege,K., Grajecki,D., Zyriax,B.C., Detinkina,E., Zu,E.C., and Buhling,K.J. (2011). Impact of

Duncker,S.C., Wang,L., Hols,P., and Bienenstock,J. (2008). The d-alanine content of lipoteichoic

Ege,M.J., Herzum,I., Buchele,G., Krauss-Etschmann,S., Lauener,R.P., Roponen,M.,

Ewaschuk,J.B., Diaz,H., Meddings,L., Diederichs,B., Dmytrash,A., Backer,J., Looijer-

Falagas,M.E., Betsi,G.I., and Athanasiou,S. (2007). Probiotics for the treatment of women

Fanaro,S., Chierici,R., Guerrini,P., and Vigi,V. (2003). Intestinal microflora in early infancy:

Folster-Holst,R., Muller,F., Schnopp,N., Abeck,D., Kreiselmaier,I., Lenz,T., von,R.U.,

Garcia,C., El-Qutob,D., Martorell,A., Febrer,I., Rodriguez,M., Cerda,J.C., and Felix,R. (2007).

Gonzalez,d.l.R., I, Inigo,J.F., and Oehling,A. (1971). The importance of food sensitization in

with bacterial vaginosis. Clin. Microbiol. Infect. *13*, 657-664.

to severe atopic dermatitis. Br. J Dermatol. *155*, 1256-1261.

Allergol. Immunopathol. (Madr. ) *35*, 15-20.

atopic dermatitis. Dermatologica *143*, 288-291.

composition and development. Acta Paediatr. Suppl *91*, 48-55.

perception in a rat colorectal distension model. Neurogastroenterol. Motil. Eckburg,P.B., Bik,E.M., Bernstein,C.N., Purdom,E., Dethlefsen,L., Sargent,M., Gill,S.R.,

new probiotic candidates. J. Appl. Microbiol. *104*, 1119-1127.

childhood - a meta-analysis. Br. J. Nutr. 1-6.

flora. Science *308*, 1635-1638.

Physiol *295*, G1025-G1034.

*122*, 407-12, 412.

prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol. Neonate *82*, 103-108. Delgado,S., O'Sullivan,E., Fitzgerald,G., and Mayo,B. (2008). In vitro evaluation of the

probiotic properties of human intestinal Bifidobacterium species and selection of

Haugen,H.S., Maurer,M., Harder,B., Johnston,J., Bort,S., Mudri,S., Kuijper,J.L., Bukowski,T., Shea,P., Dong,D.L., Dasovich,M., Grant,F.J., Lockwood,L., Levin,S.D., LeCiel,C., Waggie,K., Day,H., Topouzis,S., Kramer,J., Kuestner,R., Chen,Z., Foster,D., Parrish-Novak,J., and Gross,J.A. (2004). Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat. Immunol. *5*, 752-760.

maternal supplementation with probiotics during pregnancy on atopic eczema in

acid is crucial for Lactobacillus plantarum-mediated protection from visceral pain

Nelson,K.E., and Relman,D.A. (2005). Diversity of the human intestinal microbial

Hyvarinen,A., Vuitton,D.A., Riedler,J., Brunekreef,B., Dalphin,J.C., Braun-Fahrlander,C., Pekkanen,J., Renz,H., and von Mutius,E. (2008). Prenatal exposure to a farm environment modifies atopic sensitization at birth. J. Allergy Clin. Immunol.

van,L.M., and Madsen,K.L. (2008). Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am. J. Physiol Gastrointest. Liver

Schrezenmeir,J., Christophers,E., and Weichenthal,M. (2006). Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate

Sensitization in early age to food allergens in children with atopic dermatitis.


Ait-Belgnaoui,A., Han,W., Lamine,F., Eutamene,H., Fioramonti,J., Bueno,L., and

Akei,H.S., Mishra,A., Blanchard,C., and Rothenberg,M.E. (2005). Epicutaneous antigen

Asahara,T., Nomoto,K., Watanuki,M., and Yokokura,T. (2001). Antimicrobial activity of

Asher,M.I., Montefort,S., Bjorksten,B., Lai,C.K., Strachan,D.P., Weiland,S.K., and Williams,H.

Baba,N., Samson,S., Bourdet-Sicard,R., Rubio,M., and Sarfati,M. (2008). Commensal bacteria

Bin-Nun,A., Bromiker,R., Wilschanski,M., Kaplan,M., Rudensky,B., Caplan,M., and

Boirivant,M. and Strober,W. (2007). The mechanism of action of probiotics. Curr. Opin.

Brenner,D.M., Moeller,M.J., Chey,W.D., and Schoenfeld,P.S. (2009). The utility of probiotics

Brouwer,M.L., Wolt-Plompen,S.A., Dubois,A.E., van der Heide,S., Jansen,D.F.,

BuBmann,C., Bieber,T., and Novak,N. (2009). Systemic therapeutic options for severe atopic

Carroll,I.M., Andrus,J.M., Bruno-Barcena,J.M., Klaenhammer,T.R., Hassan,H.M., and

animal model to study atopic dermatitis. J. Invest Dermatol. *117*, 977-983. Chapat,L., Chemin,K., Dubois,B., Bourdet-Sicard,R., and Kaiserlian,D. (2004).

Cryan,J.F. and O'Mahony,S.M. (2011). The microbiome-gut-brain axis: from bowel to

multicountry cross-sectional surveys. Lancet *368*, 733-743.

non-Tr1 suppressor T cells. J. Leukoc. Biol. *84*, 468-476. Bieber,T. (2008). Atopic dermatitis. N. Engl. J. Med. *358*, 1483-1494.

low birth weight neonates. J. Pediatr. *147*, 192-196.

dermatitis. J. Dtsch. Dermatol. Ges. *7*, 205-219.

behavior. Neurogastroenterol. Motil. *23*, 187-192.

cytoskeleton contraction. Gut *55*, 1090-1094.

Gastroenterology *129*, 985-994.

Gastroenterol. *23*, 679-692.

Gastroenterol. *104*, 1033-1049.

Allergy *36*, 899-906.

Immunol. *34*, 2520-2528.

Theodorou,V. (2006). Lactobacillus farciminis treatment suppresses stress induced visceral hypersensitivity: a possible action through interaction with epithelial cell

exposure primes for experimental eosinophilic esophagitis in mice.

intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection. Antimicrob. Agents Chemother. *45*, 1751-1760.

(2006). Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat

trigger a full dendritic cell maturation program that promotes the expansion of

Hammerman,C. (2005). Oral probiotics prevent necrotizing enterocolitis in very

in the treatment of irritable bowel syndrome: a systematic review. Am. J.

Hoijer,M.A., Kauffman,H.F., and Duiverman,E.J. (2006). No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. Clin. Exp.

Threadgill,D.S. (2007). Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis. Am. J. Physiol Gastrointest. Liver Physiol *293*, G729-G738. Chan,L.S., Robinson,N., and Xu,L. (2001). Expression of interleukin-4 in the epidermis of

transgenic mice results in a pruritic inflammatory skin disease: an experimental

Lactobacillus casei reduces CD8+ T cell-mediated skin inflammation. Eur. J.


Probiotics and Atopic Dermatitis 345

Huang,C.H., Kuo,I.C., Xu,H., Lee,Y.S., and Chua,K.Y. (2003a). Mite allergen induces allergic

Huang,C.H., Kuo,I.C., Xu,H., Lee,Y.S., and Chua,K.Y. (2003b). Mite allergen induces allergic

Huurre,A., Laitinen,K., Rautava,S., Korkeamaki,M., and Isolauri,E. (2008). Impact of maternal

Inoue,R., Otsuka,M., Nishio,A., and Ushida,K. (2007). Primary administration of

Iovieno,A., Lambiase,A., Sacchetti,M., Stampachiacchiere,B., Micera,A., and Bonini,S. (2008).

Isolauri,E., Arvola,T., Sutas,Y., Moilanen,E., and Salminen,S. (2000). Probiotics in the

Jin,H., He,R., Oyoshi,M., and Geha,R.S. (2009). Animal models of atopic dermatitis. J. Invest

Kalliomaki,M., Antoine,J.M., Herz,U., Rijkers,G.T., Wells,J.M., and Mercenier,A. (2010).

Kalliomaki,M., Salminen,S., Arvilommi,H., Kero,P., Koskinen,P., and Isolauri,E. (2001).

Kalliomaki,M., Salminen,S., Poussa,T., Arvilommi,H., and Isolauri,E. (2003). Probiotics and

Kalliomaki,M., Salminen,S., Poussa,T., and Isolauri,E. (2007). Probiotics during the first 7

Karczewski,J., Troost,F.J., Konings,I., Dekker,J., Kleerebezem,M., Brummer,R.J., and

Kawai,T. and Akira,S. (2010). The role of pattern-recognition receptors in innate immunity:

Kelly,D., King,T., and Aminov,R. (2007). Importance of microbial colonization of the gut in

Kim,J.Y., Kwon,J.H., Ahn,S.H., Lee,S.I., Han,Y.S., Choi,Y.O., Lee,S.Y., Ahn,K.M., and

controlled trial. J. Allergy Clin. Immunol. *119*, 1019-1021.

J. Physiol Gastrointest. Liver Physiol *298*, G851-G859.

update on Toll-like receptors. Nat. Immunol. *11*, 373-384.

early life to the development of immunity. Mutat. Res. *622*, 58-69.

management of atopic eczema. Clin. Exp. Allergy *30*, 1604-1610.

double-blind placebo-controlled study. Clin. Exp. Allergy *38*, 1342-1348. Illi,S., von,M.E., Lau,S., Nickel,R., Gruber,C., Niggemann,B., and Wahn,U. (2004). The

with asthma. J. Allergy Clin. Immunol. *113*, 925-931.

mice. FEMS Immunol Med. Microbiol. *50*, 67-76.

*121*, 289-293.

*121*, 289-293.

Dermatol. *129*, 31-40.

controlled trial. Lancet *357*, 1076-1079.

trial. Lancet *361*, 1869-1871.

721S.

dermatitis with concomitant neurogenic inflammation in mouse. J. Invest Dermatol.

dermatitis with concomitant neurogenic inflammation in mouse. J. Invest Dermatol.

atopy and probiotic supplementation during pregnancy on infant sensitization: a

natural course of atopic dermatitis from birth to age 7 years and the association

Lactobacillus johnsonii NCC533 in weaning period suppresses the elevation of proinflammatory cytokines and CD86 gene expressions in skin lesions in NC/Nga

Preliminary evidence of the efficacy of probiotic eye-drop treatment in patients with vernal keratoconjunctivitis. Graefes Arch. Clin. Exp. Ophthalmol. *246*, 435-441.

Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of allergic diseases by probiotics. J. Nutr. *140*, 713S-

Probiotics in primary prevention of atopic disease: a randomised placebo-

prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled

years of life: a cumulative risk reduction of eczema in a randomized, placebo-

Wells,J.M. (2010). Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am.

Ji,G.E. (2010). Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium


Grangette,C., Nutten,S., Palumbo,E., Morath,S., Hermann,C., Dewulf,J., Pot,B., Hartung,T.,

Grimoud,J., Durand,H., de,S.S., Monsan,P., Ouarne,F., Theodorou,V., and Roques,C. (2010).

Gruber,C., Wendt,M., Sulser,C., Lau,S., Kulig,M., Wahn,U., Werfel,T., and Niggemann,B.

Gueimonde,M. and Salminen,S. (2006). New methods for selecting and evaluating

Hacini-Rachinel,F., Gheit,H., Le Luduec,J.B., Dif,F., Nancey,S., and Kaiserlian,D. (2009). Oral

Hahn,E.L. and Bacharier,L.B. (2005). The atopic march: the pattern of allergic disease development in childhood. Immunol. Allergy Clin. North Am. *25*, 231-46, v. Haller,D., Colbus,H., Ganzle,M.G., Scherenbacher,P., Bode,C., and Hammes,W.P. (2001).

Han,D.K., Kim,M.K., Yoo,J.E., Choi,S.Y., Kwon,B.C., Sohn,M.H., Kim,K.E., and Lee,S.Y.

Hansson,L., Backman,A., Ny,A., Edlund,M., Ekholm,E., Ekstrand,H.B., Tornell,J.,

Heratizadeh,A., Wichmann,K., and Werfel,T. (2011). Food allergy and atopic dermatitis:

Heuvelin,E., Lebreton,C., Bichara,M., Cerf-Bensussan,N., and Heyman,M. (2010). A

Hikita,I., Yoshioka,T., Mizoguchi,T., Tsukahara,K., Tsuru,K., Nagai,H., Hirasawa,T.,

Hol,J., van Leer,E.H., Elink Schuurman,B.E., de Ruiter,L.F., Samsom,J.N., Hop,W.,

Hsu,C.K., Akiyama,M., and Shimizu,H. (2008). Filaggrin: an emerging star in atopic march.

how are they connected? Curr. Allergy Asthma Rep. *11*, 284-291.

by human intestinal epithelial cells. J. Nutr. *140*, 7-11.

controlled trial. J. Allergy Clin. Immunol. *121*, 1448-1454.

J. Formos. Med. Assoc. *107*, 429-431.

anti-proliferative effects. Int. J. Food Microbiol. *144*, 42-50.

fermented food origin. Syst. Appl. Microbiol. *24*, 218-226.

probiotics. Dig. Liver Dis. *38 Suppl 2*, S242-S247.

treatment of atopic dermatitis in infancy. Allergy *62*, 1270-1276.

Acad. Sci. U. S. A *102*, 10321-10326.

cells. PLoS. ONE. *4*, e4903.

Yonsei Med. J. *45*, 803-809.

153.

dermatitis. J. Invest Dermatol. *118*, 444-449.

Hols,P., and Mercenier,A. (2005). Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc. Natl.

In vitro screening of probiotics and synbiotics according to anti-inflammatory and

(2007). Randomized, placebo-controlled trial of Lactobacillus rhamnosus GG as

probiotic control skin inflammation by acting on both effector and regulatory T

Metabolic and functional properties of lactic acid bacteria in the gastro-intestinal ecosystem: a comparative in vitro study between bacteria of intestinal and

(2004). Food sensitization in infants and young children with atopic dermatitis.

Wallbrandt,P., Wennbo,H., and Egelrud,T. (2002). Epidermal overexpression of stratum corneum chymotryptic enzyme in mice: a model for chronic itchy

Bifidobacterium probiotic strain and its soluble factors alleviate chloride secretion

Tsuruta,Y., Suzuki,R., Ichihashi,M., and Horikawa,T. (2002). Characterization of dermatitis arising spontaneously in DS-Nh mice maintained under conventional conditions: another possible model for atopic dermatitis. J. Dermatol. Sci. *30*, 142-

Neijens,H.J., de Jongste,J.C., and Nieuwenhuis,E.E. (2008). The acquisition of tolerance toward cow's milk through probiotic supplementation: a randomized,


Probiotics and Atopic Dermatitis 347

Li,X.M., Kleiner,G., Huang,C.K., Lee,S.Y., Schofield,B., Soter,N.A., and Sampson,H.A. (2001).

Madsen,K., Cornish,A., Soper,P., McKaigney,C., Jijon,H., Yachimec,C., Doyle,J., Jewell,L.,

Majamaa,H. and Isolauri,E. (1997). Probiotics: a novel approach in the management of food

Man,M.Q., Hatano,Y., Lee,S.H., Man,M., Chang,S., Feingold,K.R., Leung,D.Y., Holleran,W.,

Marco,M.L., Peters,T.H., Bongers,R.S., Molenaar,D., van,H.S., Sonnenburg,J.L., Gordon,J.I.,

Marsella,R. (2009). Evaluation of Lactobacillus rhamnosus strain GG for the prevention of

Marsella,R. and Girolomoni,G. (2009). Canine models of atopic dermatitis: a useful tool with

Martindale,S., McNeill,G., Devereux,G., Campbell,D., Russell,G., and Seaton,A. (2005).

Matsuda,H., Watanabe,N., Geba,G.P., Sperl,J., Tsudzuki,M., Hiroi,J., Matsumoto,M.,

Matsumoto,K., Mizukoshi,K., Oyobikawa,M., Ohshima,H., and Tagami,H. (2004).

Meijerink,M., van,H.S., Taverne,N., Wels,M., de,V.P., Bron,P.A., Savelkoul,H.F., van,B.J.,

Mercenier,A., Lenoir-Wijnkoop,I., and Sanders,M.E. (2008). Physiological and Functional

Miniello,V.L., Brunetti,L., Tesse,R., Natile,M., Armenio,L., and Francavilla,R. (2010).

using comparative genome hybridization. PLoS. ONE. *5*, e10632.

Properties of Probiotics. Bulletin of International Dairy Federation.

epithelial barrier function. Gastroenterology *121*, 580-591.

allergy. J. Allergy Clin. Immunol. *99*, 179-185.

caecum. Environ. Microbiol. *11*, 2747-2757.

instruments. Skin Res. Technol. *10*, 122-129.

Metchnikoff,E. (1908). Optimistic studies. Putman's Sons 161-183.

atopic dermatitis in dogs. Am. J. Vet. Res. *70*, 735-740.

untapped potential. J. Invest Dermatol. *129*, 2351-2357.

years of life. Am. J. Respir. Crit Care Med. *171*, 121-128.

Clin. Immunol. *107*, 693-702.

Invest Dermatol. *128*, 79-86.

Immunol *9*, 461-466.

Murine model of atopic dermatitis associated with food hypersensitivity. J. Allergy

and De Simone,C. (2001). Probiotic bacteria enhance murine and human intestinal

Uchida,Y., and Elias,P.M. (2008). Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges. J.

and Kleerebezem,M. (2009). Lifestyle of Lactobacillus plantarum in the mouse

Antioxidant intake in pregnancy in relation to wheeze and eczema in the first two

Ushio,H., Saito,S., Askenase,P.W., and Ra,C. (1997). Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int

Establishment of an atopic dermatitis-like skin model in a hairless mouse by repeated elicitation of contact hypersensitivity that enables to conduct functional analyses of the stratum corneum with various non-invasive biophysical

Kleerebezem,M., and Wells,J.M. (2010). Identification of genetic loci in Lactobacillus plantarum that modulate the immune response of dendritic cells

Lactobacillus reuteri modulates cytokines production in exhaled breath condensate of children with atopic dermatitis. J. Pediatr. Gastroenterol. Nutr. *50*, 573-576. Mohamadzadeh,M., Olson,S., Kalina,W.V., Ruthel,G., Demmin,G.L., Warfield,K.L., Bavari,S.,

and Klaenhammer,T.R. (2005). Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc. Natl. Acad. Sci. U. S. A *102*, 2880-2885.

lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a doubleblind, randomized, placebo-controlled trial. Pediatr. Allergy Immunol. *21*, e386 e393.


Kirjavainen,P.V., Arvola,T., Salminen,S.J., and Isolauri,E. (2002). Aberrant composition of

Kirjavainen,P.V., Salminen,S.J., and Isolauri,E. (2003). Probiotic bacteria in the management

Konishi,H., Tsutsui,H., Murakami,T., Yumikura-Futatsugi,S., Yamanaka,K., Tanaka,M.,

Kopp,M.V., Hennemuth,I., Heinzmann,A., and Urbanek,R. (2008). Randomized, double-

Kukkonen,K., Kuitunen,M., Haahtela,T., Korpela,R., Poussa,T., and Savilahti,E. (2010). High

Kukkonen,K., Savilahti,E., Haahtela,T., Juntunen-Backman,K., Korpela,R., Poussa,T.,

Kukkonen,K., Savilahti,E., Haahtela,T., Juntunen-Backman,K., Korpela,R., Poussa,T.,

Laouini,D., Kawamoto,S., Yalcindag,A., Bryce,P., Mizoguchi,E., Oettgen,H., and Geha,R.S.

Laubereau,B., Filipiak-Pittroff,B., von Berg,A., Grubl,A., Reinhardt,D., Wichmann,H.E.,

Lebeer,S., Vanderleyden,J., and De Keersmaecker,S.C. (2010). Host interactions of probiotic

Li,M., Messaddeq,N., Teletin,M., Pasquali,J.L., Metzger,D., and Chambon,P. (2005). Retinoid

effects of Lactobacillus GG supplementation. Pediatrics *121*, e850-e856. Kuitunen,M., Kukkonen,K., Juntunen-Backman,K., Korpela,R., Poussa,T., Tuure,T.,

conditions. Proc. Natl. Acad. Sci. U. S. A *99*, 11340-11345.

controlled trial. J Allergy Clin. Immunol *119*, 192-198.

blind, placebo-controlled trial. Pediatrics *122*, 8-12.

inflammation. J. Allergy Clin. Immunol. *112*, 981-987.

e393.

997.

Microbiol. *8*, 171-184.

14795-14800.

Gut *51*, 51-55.

Nutr. *36*, 223-227.

Clin. Immunol. *123*, 335-341.

Pediatr. Allergy Immunol. *21*, 67-73.

lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a doubleblind, randomized, placebo-controlled trial. Pediatr. Allergy Immunol. *21*, e386-

gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning?

of atopic disease: underscoring the importance of viability. J. Pediatr. Gastroenterol.

Iwakura,Y., Suzuki,N., Takeda,K., Akira,S., Nakanishi,K., and Mizutani,H. (2002). IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free

blind, placebo-controlled trial of probiotics for primary prevention: no clinical

Haahtela,T., and Savilahti,E. (2009). Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J. Allergy

intestinal IgA associates with reduced risk of IgE-associated allergic diseases.

Tuure,T., and Kuitunen,M. (2007). Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-

Tuure,T., and Kuitunen,M. (2008). Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-

(2003). Epicutaneous sensitization with superantigen induces allergic skin

and Koletzko,S. (2004). Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Arch. Dis. Child *89*, 993-

bacterial surface molecules: comparison with commensals and pathogens. Nat. Rev.

X receptor ablation in adult mouse keratinocytes generates an atopic dermatitis triggered by thymic stromal lymphopoietin. Proc. Natl. Acad. Sci. U. S. A *102*,


Probiotics and Atopic Dermatitis 349

Passeron,T., Lacour,J.P., Fontas,E., and Ortonne,J.P. (2006). Prebiotics and synbiotics: two

Penders,J., Stobberingh,E.E., van den Brandt,P.A., and Thijs,C. (2007). The role of the

Perea,V.M., Verhoeven,T.L., Draing,C., Von,A.S., Pfitzenmaier,M., Geyer,A., Lambrichts,I.,

Peserico,A., Stadtler,G., Sebastian,M., Fernandez,R.S., Vick,K., and Bieber,T. (2008). Reduction

randomized, double-blind, controlled study. Br. J. Dermatol. *158*, 801-807. Prescott,S.L. and Bjorksten,B. (2007). Probiotics for the prevention or treatment of allergic

Rachmilewitz,D., Karmeli,F., Takabayashi,K., Hayashi,T., Leider-Trejo,L., Lee,J., Leoni,L.M.,

Rachmilewitz,D., Katakura,K., Karmeli,F., Hayashi,T., Reinus,C., Rudensky,B., Akira,S.,

Rautava,S., Kalliomaki,M., and Isolauri,E. (2002). Probiotics during pregnancy and breast-

Resta-Lenert,S. and Barrett,K.E. (2003). Live probiotics protect intestinal epithelial cells from

Roessler,A., Friedrich,U., Vogelsang,H., Bauer,A., Kaatz,M., Hipler,U.C., Schmidt,I., and

Rosenfeldt,V., Benfeldt,E., Nielsen,S.D., Michaelsen,K.F., Jeppesen,D.L., Valerius,N.H., and

Salminen,S. and Gueimonde,M. (2005). Gut microbiota in infants between 6 and 24 months

Salminen,S.J., Gueimonde,M., and Isolauri,E. (2005). Probiotics that modify disease risk. J.

Sanders,M.E. (2008). Use of probiotics and yogurts in maintenance of health. J. Clin.

Santosa,S., Farnworth,E., and Jones,P.J. (2006). Probiotics and their potential health claims.

Sawada,J., Morita,H., Tanaka,A., Salminen,S., He,F., and Matsuda,H. (2007). Ingestion of

heat-treated Lactobacillus rhamnosus GG prevents development of atopic

atopic dermatitis. J. Allergy Clin. Immunol. *111*, 389-395.

of age. Nestle. Nutr. Workshop Ser. Pediatr. Program. *56*, 43-51.

dermatitis in NC/Nga mice. Clin. Exp. Allergy *37*, 296-303.

rhamnosus GG. Appl. Environ. Microbiol. *73*, 3595-3604.

spontaneous murine colitis. Gastroenterology *122*, 1428-1441.

diseases. J. Allergy Clin. Immunol. *120*, 255-262.

infant. J. Allergy Clin. Immunol. *109*, 119-121.

Gastroenterology *126*, 520-528.

Allergy *38*, 93-102.

Nutr. *135*, 1294-1298.

Nutr. Rev. *64*, 265-274.

Gastroenterol. *42 Suppl 2*, S71-S74.

years. Allergy *61*, 431-437.

promising approaches for the treatment of atopic dermatitis in children above 2

intestinal microbiota in the development of atopic disorders. Allergy *62*, 1223-1236.

Grangette,C., Pot,B., Vanderleyden,J., and De Keersmaecker,S.C. (2007). Functional analysis of D-alanylation of lipoteichoic acid in the probiotic strain Lactobacillus

of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre,

and Raz,E. (2002). Immunostimulatory DNA ameliorates experimental and

Takeda,K., Lee,J., Takabayashi,K., and Raz,E. (2004). Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis.

feeding might confer immunomodulatory protection against atopic disease in the

the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut *52*, 988-997.

Jahreis,G. (2008). The immune system in healthy adults and patients with atopic dermatitis seems to be affected differently by a probiotic intervention. Clin. Exp.

Paerregaard,A. (2003). Effect of probiotic Lactobacillus strains in children with


Mohamadzadeh,M., Pfeiler,E.A., Brown,J.B., Zadeh,M., Gramarossa,M., Managlia,E.,

Morisset,M., Aubert-Jacquin,C., Soulaines,P., Moneret-Vautrin,D.A., and Dupont,C. (2011).

events in infants at high risk of allergy. Eur. J. Clin. Nutr. *65*, 175-183. Moroi,M., Uchi,S., Nakamura,K., Sato,S., Shimizu,N., Fujii,M., Kumagai,T., Saito,M.,

paracasei K71 on adult type atopic dermatitis. J. Dermatol. *38*, 131-139. Nagelkerken,L., Verzaal,P., Lagerweij,T., Persoon-Deen,C., Berbee,J.F., Prens,E.P.,

first 2 years of life. Pediatr. Allergy Immunol. *15*, 48-54.

transgenic for human apolipoprotein C1. J. Invest Dermatol. *128*, 1165-1172. Negele,K., Heinrich,J., Borte,M., von Berg,A., Schaaf,B., Lehmann,I., Wichmann,H.E., and

Nermes,M., Kantele,J.M., Atosuo,T.J., Salminen,S., and Isolauri,E. (2011). Interaction of

Niers,L., Martin,R., Rijkers,G., Sengers,F., Timmerman,H., van,U.N., Smidt,H., Kimpen,J.,

Niers,L.E., Hoekstra,M.O., Timmerman,H.M., van Uden,N.O., de Graaf,P.M., Smits,H.H.,

O'Hara,A.M. and Shanahan,F. (2007). Mechanisms of action of probiotics in intestinal

Ohland,C.L. and MacNaughton,W.K. (2010). Probiotic bacteria and intestinal epithelial barrier function. Am. J. Physiol Gastrointest. Liver Physiol *298*, G807-G819. Ortiz-Andrellucchi,A., Sanchez-Villegas,A., Rodriguez-Gallego,C., Lemes,A., Molero,T.,

Parvez,S., Malik,K.A., Ah,K.S., and Kim,H.Y. (2006). Probiotics and their fermented food products are beneficial for health. J. Appl. Microbiol. *100*, 1171-1185.

development of eczema (the PandA study). Allergy *64*, 1349-1358.

Nomoto,K. (2005). Prevention of infections by probiotics. J. Biosci. Bioeng. *100*, 583-592. Nova,E., Warnberg,J., Gomez-Martinez,S., Diaz,L.E., Romeo,J., and Marcos,A. (2007).

A *108 Suppl 1*, 4623-4630.

370-377.

Immunol. *149*, 344-352.

diseases. ScientificWorldJournal. *7*, 31-46.

*Suppl 1*, S90-S95.

J. Nutr. 1-12.

Bere,P., Sarraj,B., Khan,M.W., Pakanati,K.C., Ansari,M.J., O'Flaherty,S., Barrett,T., and Klaenhammer,T.R. (2011). Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc. Natl. Acad. Sci. U. S.

A non-hydrolyzed, fermented milk formula reduces digestive and respiratory

Uchiyama,K., Watanabe,T., Yamaguchi,H., Yamamoto,T., Takeuchi,S., and Furue,M. (2011). Beneficial effect of a diet containing heat-killed Lactobacillus

Havekes,L.M., and Oranje,A.P. (2008). Development of atopic dermatitis in mice

Bolte,G. (2004). Mode of delivery and development of atopic disease during the

orally administered Lactobacillus rhamnosus GG with skin and gut microbiota and humoral immunity in infants with atopic dermatitis. Clin. Exp. Allergy *41*,

and Hoekstra,M. (2009). The effects of selected probiotic strains on the

Kimpen,J.L., and Rijkers,G.T. (2007). Selection of probiotic bacteria for prevention of allergic diseases: immunomodulation of neonatal dendritic cells. Clin. Exp.

Immunomodulatory effects of probiotics in different stages of life. Br. J. Nutr. *98* 

Soria,A., Pena-Quintana,L., Santana,M., Ramirez,O., Garcia,J., Cabrera,F., Cobo,J., and Serra-Majem,L. (2008). Immunomodulatory effects of the intake of fermented milk with Lactobacillus casei DN114001 in lactating mothers and their children. Br.


Probiotics and Atopic Dermatitis 351

Tsukuba,T., Okamoto,K., Okamoto,Y., Yanagawa,M., Kohmura,K., Yasuda,Y., Uchi,H.,

Ulluwishewa,D., Anderson,R.C., McNabb,W.C., Moughan,P.J., Wells,J.M., and Roy,N.C.

Vael,C. and Desager,K. (2009). The importance of the development of the intestinal

van der Aa,L.B., Heymans,H.S., van Aalderen,W.M., Sillevis Smitt,J.H., Knol,J., Ben,A.K.,

Vesterlund,S., Karp,M., Salminen,S., and Ouwehand,A.C. (2006). Staphylococcus aureus

Viljanen,M., Savilahti,E., Haahtela,T., Juntunen-Backman,K., Korpela,R., Poussa,T., Tuure,T.,

and suburban populations across Europe. Clin. Exp. Allergy *37*, 661-670. Wells, J. M. Immunomodulatory mechanisms of lactobacilli. Microbial Cell Factories . 2011.

Wells,J.M., Loonen,L.M., and Karczewski,J.M. (2010). The role of innate signaling in the

Wells,J.M., Rossi,O., Meijerink,M., and Van Baarlen,P. (2011). Epithelial crosstalk at the microbiota-mucosal interface. Proc. Natl. Acad. Sci. U. S. A *108 Suppl 1*, 4607-4614. West,C.E., Hammarstrom,M.L., and Hernell,O. (2009). Probiotics during weaning reduce the

Weston,S., Halbert,A., Richmond,P., and Prescott,S.L. (2005). Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch. Dis. Child *90*, 892-897. Wickens,K., Black,P.N., Stanley,T.V., Mitchell,E., Fitzharris,P., Tannock,G.W., Purdie,G., and

Williams,H., Robertson,C., Stewart,A., Ait-Khaled,N., Anabwani,G., Anderson,R., Asher,I.,

incidence of eczema. Pediatr. Allergy Immunol. *20*, 430-437.

Allergies in Childhood. J. Allergy Clin. Immunol. *103*, 125-138.

atopic dermatitis. J. Biochem. *134*, 893-902.

microbiota in infancy. Curr. Opin. Pediatr. *21*, 794-800.

components. J. Nutr. *141*, 769-776.

bacteria. Microbiology *152*, 1819-1826.

795-804.

10(S1):S17.

41-48.

Immunol.

Nakahara,T., Furue,M., Nakayama,K., Kadowaki,T., Yamamoto,K., and Nakayama,K.I. (2003). Association of cathepsin E deficiency with development of

(2011). Regulation of tight junction permeability by intestinal bacteria and dietary

Goossens,D.A., and Sprikkelman,A.B. (2010). Effect of a new synbiotic mixture on atopic dermatitis in infants: a randomized-controlled trial. Clin. Exp. Allergy *40*,

adheres to human intestinal mucus but can be displaced by certain lactic acid

and Kuitunen,M. (2005). Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy *60*, 494-500. Waser,M., Michels,K.B., Bieli,C., Floistrup,H., Pershagen,G., von Mutius,E., Ege,M., Riedler,J.,

Schram-Bijkerk,D., Brunekreef,B., van Hage,M., Lauener,R., and Braun-Fahrlander,C. (2007). Inverse association of farm milk consumption with asthma and allergy in rural

homeostasis of tolerance and immunity in the intestine. Int. J. Med. Microbiol. *300*,

Crane,J. (2008). A differential effect of 2 probiotics in the prevention of eczema and atopy: A double-blind, randomized, placebo-controlled trial. J. Allergy Clin.

Beasley,R., Bjorksten,B., Burr,M., Clayton,T., Crane,J., Ellwood,P., Keil,U., Lai,C., Mallol,J., Martinez,F., Mitchell,E., Montefort,S., Pearce,N., Shah,J., Sibbald,B., Strachan,D., von,M.E., and Weiland,S.K. (1999). Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and


Tissier,H. (1906). CR. Soc Biol *60*, 359.

Torii,S., Torii,A., Itoh,K., Urisu,A., Terada,A., Fujisawa,T., Yamada,K., Suzuki,H., Ishida,Y., Nakamura,F., Kanzato,H., Sawada,D., Nonaka,A., Hatanaka,M., and Fujiwara,S. (2011). Effects of oral administration of Lactobacillus acidophilus L-92 on the symptoms and serum markers of atopic dermatitis in children. Int. Arch. Allergy Immunol. *154*, 236-245.

Schaub,B., Lauener,R., and von Mutius,E. (2006). The many faces of the hygiene hypothesis.

Segawa,S., Hayashi,A., Nakakita,Y., Kaneda,H., Watari,J., and Yasui,H. (2008). Oral

Sicherer,S.H. and Burks,A.W. (2008). Maternal and infant diets for prevention of allergic diseases: understanding menu changes in 2008. J. Allergy Clin. Immunol. *122*, 29-33. Sistek,D., Kelly,R., Wickens,K., Stanley,T., Fitzharris,P., and Crane,J. (2006). Is the effect of

Sjogren,Y.M., Tomicic,S., Lundberg,A., Bottcher,M.F., Bjorksten,B., Sverremark-

Soh,S.E., Aw,M., Gerez,I., Chong,Y.S., Rauff,M., Ng,Y.P., Wong,H.B., Pai,N., Lee,B.W., and

Spergel,J.M., Mizoguchi,E., Brewer,J.P., Martin,T.R., Bhan,A.K., and Geha,R.S. (1998).

Spergel,J.M. and Paller,A.S. (2003). Atopic dermatitis and the atopic march. J. Allergy Clin.

Suzuki,Y., Kodama,M., and Asano,K. (2011). Skin barrier-related molecules and

Tanaka,A., Fukushima,Y., Benyacoub,J., Blum,S., and Matsuda,H. (2008). Prophylactic effect

Taylor,A.L., Dunstan,J.A., and Prescott,S.L. (2007). Probiotic supplementation for the first 6

Torii,S., Torii,A., Itoh,K., Urisu,A., Terada,A., Fujisawa,T., Yamada,K., Suzuki,H., Ishida,Y.,

aerosolized antigen in mice. J. Clin. Invest *101*, 1614-1622.

pathophysiology of asthma. Allergol. Int. *60*, 11-15.

dermatitis model NC/Nga mice. Biol. Pharm. Bull. *31*, 884-889.

administration of heat-killed Lactobacillus brevis SBC8803 ameliorates the development of dermatitis and inhibits immunoglobulin E production in atopic

probiotics on atopic dermatitis confined to food sensitized children? Clin. Exp.

Ekstrom,E., and Jenmalm,M.C. (2009). Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses. Clin. Exp.

Shek,L.P. (2009). Probiotic supplementation in the first 6 months of life in at risk Asian infants--effects on eczema and atopic sensitization at the age of 1 year. Clin.

Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to

of oral administration of Lactobacillus johnsonii NCC533 (La1) during the weaning period on atopic dermatitis in NC/NgaTnd mice. Eur. J. Dermatol. *18*, 136-140. Tanaka,A., Jung,K., Benyacoub,J., Prioult,G., Okamoto,N., Ohmori,K., Blum,S.,

Mercenier,A., and Matsuda,H. (2009). Oral supplementation with Lactobacillus rhamnosus CGMCC 1.3724 prevents development of atopic dermatitis in NC/NgaTnd mice possibly by modulating local production of IFN-gamma. Exp.

months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J. Allergy

Nakamura,F., Kanzato,H., Sawada,D., Nonaka,A., Hatanaka,M., and Fujiwara,S. (2011). Effects of oral administration of Lactobacillus acidophilus L-92 on the symptoms and serum markers of atopic dermatitis in children. Int. Arch. Allergy

J. Allergy Clin. Immunol. *117*, 969-977.

Allergy *36*, 629-633.

Allergy *39*, 1842-1851.

Exp. Allergy *39*, 571-578.

Immunol. *112*, S118-S127.

Dermatol. *18*, 1022-1027.

Clin. Immunol. *119*, 184-191.

Tissier,H. (1906). CR. Soc Biol *60*, 359.

Immunol. *154*, 236-245.


**21** 

Öner Özdemir

*Turkey* 

**The Role of Probiotics in Atopic Dermatitis** 

Development of the child's immune system tends to be directed toward a T-helper 2 (Th2) phenotype in infants, whereas postnatal maturation is associated with gradual inhibition of Th2 and increasing Th1 affinity [1]. Thus, immature Th2-dominant neonatal responses must undergo environment-driven maturation via microbial contact in the early postnatal period to prevent development of childhood allergic diseases. Nevertheless, nowadays the increased use of antimicrobial medication, the consumption of sterile food, and reduced family size that result in lower rates of infection during childhood also reduce early contact to microbes. Consequentially, at an early age the infant`s immune system results in subsequent polarization toward a Th2 phenotype during postnatal maturation. Among several other phenomena, the present increase in allergic diseases seen in the industrialized countries has been attributed, to a relative lack of microbial stimulation of the infantile gut immune system and the exaggerated hygiene of the typical western lifestyle during early

The newborn is first colonized by microbes at birth. The colonization of the gut that begins promptly after birth is affected by mode of delivery, early feeding strategies and the hygienic conditions around the child (the early environment). The colonizing bacteria originate mainly from the mother's gut and vaginal tract [3]. For instance, children born by cesarean section are colonized with Bifidobacteria and Lactobacilli later than vaginally delivered children, and are shown to have more frequent respiratory allergies [4]. After delivery, breastfeeding continues to enhance the original inoculum by the introduction of specific lactic acid bacteria, Bifidobacteria and bacteria from the mother's skin, all of which enable the infant gut microbiota that is dominated by Bifidobacteria. Breast milk also contains plentiful indigestible oligosaccharides, which pass through the whole intestine and promote the growth and activity of commensal bacteria; composed mainly of Bifidobacteria [5]. These bacteria set the basis for gut microbiota development and modulation, along with

The greatest differences between breast-fed and formula-fed infants appear to be in lactic acid bacteria and Bifidobacteria colonization. Usually, Bifidobacteria appear after birth and, within a week, are reported as the dominant bacterial group, with Bifidobacterium (Bfdbm) infantis / longum / breve being the most common species in breast-fed infants [6]. In addition, Lactobacillus (Lctbs) acidophilus is the most common Lctbs in the feces of breast-

childhood. And this is known as the hygiene hypothesis [2].

environmental exposures such as antibiotic administration.

**1. Introduction** 

*Republic of Turkey, Ministry of Health, İstanbul Medeniyet University* 

**Prevention and Therapy** 

*Göztepe Research / Training Hospital* 

